Ionis Pharmaceuticals IONS signed a license agreement with Sweden-based Sobi. Per the terms, Sobi will acquire exclusive ...

Kentucky will spend $300,000 to match a $3.1 million NASA grant to support space research on disease treatments and cures.

By Guest Columnist Dr. Stephanie Duguid Our most recent speaker through the Mississippi Health Ambassador Initiative was Dr.

A cholesterol receptor protein called LDLR appears to be a key driver of neurotoxicity in sporadic ALS, per new research ...

Clene planning to submit a New Drug Application (NDA) in the second half of 2025 for potential Accelerated Approval of CNM-Au8® in ALSClene ...

The global neurodegenerative disease market is on a trajectory of significant expansion, with its valuation expected to surge from USD 52.08 billion in 2024 to USD 102.4 billion by 2034, reflecting a ...

The phase III trial COURAGE-ALS of investigational reldesemtiv, a fast skeletal troponin activator, did not meet its primary ...

UCLA Health researchers say study findings uncover Huntington's disease mechanisms and pave new ways to develop treatments.

ALZcure is pioneering blockchain-powered funding for Alzheimer's research through Decentralized Science (DeSci). Built on ...

Preclinical data with the investigational gene therapy INS1202 show improvements in survival and motor performance in ALS.

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...